Helping People and Pets Live Longer, Healthier & Fuller Lives

Rapid, Accurate Diagnostics for Better Care


Micropoint Bioscience, Inc. improves patient care by providing rapid, accurate, reliable and low-cost diagnostic products at point-of-care. The company's innovative mLabs® platform is built around patented semiconductor and microfluidic technologies, and integrated with advanced immunoassay systems.


A Global Provider of Systems and Solutions


Micropoint Bioscience is headquartered in Santa Clara, California, with GMP and ISO 13485-certified manufacturing facilities in the U.S. and Asia, and distributors around the globe. 


Join Us!


At Micropoint, we help people live longer fuller lives by creating technologies for fast testing and monitoring of critical diseases. We're actively involved in shaping the industry so that physicians have the tools to help their patients at point-of-care. Our vision requires bold leaders. If you're seeking a career that is challenging, energizing, and rewarding, we hope you’ll consider joining us as we push the boundaries of medical technology.

Meet Us at These Events




Medica 2020

November 16-19



Hall 3/ C30-16






AACC 2020

Dec 13-17 (New Date)

Chicago, IL


medica 2020 hi res.jpg

Partner with Us!

Micropoint is seeking distribution partners for the following regions. Contact us.

  • Estonia

  • Switzerland

  • Australia and New Zealand

  • Central America and Caribbean Islands

  • UAE

  • Saudi Arabia



U.S. Headquarters


Micropoint Bioscience, Inc.
3521 Leonard Court 
Santa Clara, CA 95054
United States


T:+1 (408) 588-1682
F:+1 (408) 588-1620



European Office


Micropoint Bioscience, Inc.

2 rue Eugene Sue

38100 Grenoble



T: +33 6 22 38 20 48

F: +33 4 76 09 03 50

Asian Office


Micropoint Biotechnologies Co., Ltd.

5F, Bldg 1

Runheng Dingfeng Industrial Park, Liuxian 2 Rd.

Shenzhen 518101, Guangdong



T: +86 755 21600849

F: +86 755 86673903

Copyright Micropoint Biosciences 2016

Micropoint Bioscience products are not available for sale nor marketed in the United States at this time.